Ligand Pharmaceuticals (LGND)
(Delayed Data from NSDQ)
$86.88 USD
+2.51 (2.97%)
Updated Jul 8, 2024 04:00 PM ET
After-Market: $86.88 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMEarnings News For LGND
-
Why Is Ligand (LGND) Up 4% Since Last Earnings Report?
-
Ligand (LGND) Beats Q1 Earnings, Misses Sales Estimates
-
Ligand: Q1 Earnings Snapshot
-
Ligand Pharmaceuticals (LGND) Tops Q1 Earnings Estimates
-
Ligand Reports First Quarter 2024 Financial Results
-
Ligand (LGND) Down 15.5% Since Last Earnings Report: Can It Rebound?
-
Ligand (LGND) Q4 Earnings Surpass Estimates, Stock Surges
-
Ligand: Q4 Earnings Snapshot
-
Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
-
Ligand (LGND) Up 12.4% Since Last Earnings Report: Can It Continue?
-
Ligand (LGND) Beats on Q3 Earnings & Sales, Raises '23 View
-
Ligand: Q3 Earnings Snapshot
-
Ligand Reports Third Quarter 2023 Financial Results
-
Ligand Pharmaceuticals (LGND) Earnings Expected to Grow: Should You Buy?
-
Ligand (LGND) Down 8.8% Since Last Earnings Report: Can It Rebound?
-
Ligand (LGND) Up 4% on Raised '23 EPS, Beats on Q2 Earnings
-
Ligand Pharmaceuticals (LGND) Q2 Earnings Beat Estimates
-
Ligand: Q2 Earnings Snapshot
-
Ligand Reports Second Quarter 2023 Financial Results
-
Ligand (LGND) to Post Q2 Earnings: What's in Store?
-
Ligand (LGND) Up 3% on Raised '23 View, Beats on Q1 Earnings
-
Ligand Pharmaceuticals (LGND) Surpasses Q1 Earnings and Revenue Estimates
-
Ligand: Q1 Earnings Snapshot
-
Ligand's (LGND) Q4 Sales & Earnings Top, View Raised, Stock Up
-
Ligand Pharmaceuticals (LGND) Surpasses Q4 Earnings and Revenue Estimates